| Literature DB >> 35805387 |
Veljko Kolak1, Maja Pavlovic1, Ema Aleksic1, Vladimir Biocanin1, Milica Gajic1, Ana Nikitovic1, Marija Lalovic1, Irena Melih1, Dragana Pesic1.
Abstract
The COVID-19 pandemic has drastically changed the routine way of life, having consequences in many segments of life, including dental practice and education. The aim of this study was to evaluate the frequency of probable bruxism in a sample of dental students in Serbia and to estimate the potential association between psychological factors related to the COVID-19 pandemic and the presence of bruxism. A cross-sectional study included 178 dental students in Serbia, who were interviewed using a specially-designed self-administered online questionnaire, which consisted of three sections, and after that, a clinical examination for the presence of bruxism symptoms in the oral cavity. Psychological status was evaluated using the Depression, Anxiety and Stress Scale-21 (DASS-21) and the Fear of COVID-19 Scale (FCV-19S). Saliva samples were taken to analyze salivary cortisol levels. The prevalence of probable bruxism was 34.8%. Respondents with probable bruxism had significantly higher DASS-21 and FCV-19S scores and mean values of salivary cortisol compared to non-bruxers. A history of COVID-19 infection, high stress, and fear of COVID-19 scores were associated with the presence of probable bruxism. The findings suggest that the COVID-19 pandemic has had a great psychological impact and impact on the presence and worsening of bruxism symptoms in a sample of dental students in Serbia.Entities:
Keywords: COVID-19; anxiety; bruxism; dental students; depression; fear; salivary cortisol; stress
Mesh:
Substances:
Year: 2022 PMID: 35805387 PMCID: PMC9266173 DOI: 10.3390/ijerph19137729
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1A flowchart of the recruitment process.
Distribution of respondents based on questionary answers.
| Variable | Category | Total Number (N) | Percentage (%) |
|---|---|---|---|
| Gender | Female | 94 | 52.8 |
| Male | 84 | 47.2 | |
| Been infected with COVID-19 | Yes | 70 | 39.3 |
| No | 108 | 60.7 | |
| Been hospitalized | Yes | 3 | 1.7 |
| No | 175 | 98.3 | |
| Been isolated | Yes | 151 | 84.8 |
| No | 27 | 15.2 | |
| A family member has been infected | Yes | 150 | 84.3 |
| No | 28 | 15.7 | |
| A family member has been hospitalized | Yes | 28 | 15.7 |
| No | 150 | 84.3 | |
| Fully vaccinated | Yes | 56 | 31.5 |
| No | 122 | 68.5 | |
| Self-reported sleep or awake bruxism | Yes | 62 | 34.8 |
| No | 116 | 65.2 | |
| Worsening of bruxism symptoms | Yes | 46 | 74.2 |
| No | 16 | 25.8 |
DASS-21 and FCV-19S scores of the study sample.
| Scale | Category | Mean ± SD | Range |
|---|---|---|---|
| DASS-21 | Depression | 6.04 ± 6.18 | 0–28 |
| Anxiety | 5.66 ± 7.24 | 0–36 | |
| Stress | 10.87 ± 8.27 | 0–36 | |
| Total | 22.57 ± 19.09 | 0–94 | |
| FCV-19S | |||
| Total | 12.56 ± 4.49 | 7–28 |
Distribution of respondents according to DASS-21 categories.
| Variable | Category | Total Number (N) | Percentage (%) |
|---|---|---|---|
| Depression | Normal | 128 | 71.9 |
| Mild | 28 | 15.7 | |
| Moderate | 14 | 7.9 | |
| Severe | 6 | 3.4 | |
| Extremely severe | 2 | 1.1 | |
| Anxiety | Normal | 126 | 70.8 |
| Mild | 6 | 3.4 | |
| Moderate | 28 | 15.7 | |
| Severe | 8 | 4.5 | |
| Extremely severe | 10 | 5.6 | |
| Stress | Normal | 124 | 69.7 |
| Mild | 24 | 13.5 | |
| Moderate | 19 | 10.7 | |
| Severe | 9 | 5.1 | |
| Extremely severe | 2 | 1.1 |
Difference of DASS-21 and FCV-19S scores between bruxers and non-bruxers.
| Variable | Bruxers | Non Bruxers | ||||
|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD |
| ||
| DASS-21 Depression | 8.06 | 7.94 | 4.97 | 4.68 | 3.2759 | 0.001 * |
| DASS-21 Anxiety | 9.29 | 9.83 | 3.72 | 4.31 | 5.2374 | <0.001 * |
| DASS-21 Stress | 14.87 | 8.74 | 8.72 | 7.17 | 5.0403 | <0.001 * |
| DASS-21 Total | 32.23 | 23.63 | 17.41 | 13.71 | 5.2945 | <0.001 * |
| FCV-19S | 15.06 | 4.92 | 11.22 | 3.61 | 5.9366 | <0.001 * |
* Significant at p < 0.05.
Difference of salivary cortisol concentrations between bruxers and non-bruxers.
| Group | Salivary Cortisol (nmol/L) | |||
|---|---|---|---|---|
| Mean | SD | z Value |
| |
| Bruxers | 10.99 | 7.25 | −4.6098 | <0.001 * |
| Non-bruxers | 6.65 | 1.84 | ||
* Significant at p < 0.05.
Analysis of variables associated with probable bruxism.
| Variable | Presence of Bruxism | Univariate Logistic Regression Analysis | Multivariate Logistic Analysis | |||||
|---|---|---|---|---|---|---|---|---|
| N | % | OR | 95% CI | OR | 95% CI | |||
| Gender | ||||||||
| Female | 46 | 48.9 | 4.073 | 1.760 | ||||
| Male | 16 | 19.0 | 1 | 2.07–8.03 | ˂0.001 * | 1 | 0.71–4.36 | 0.223 |
| Been positive for COVID-19 | ||||||||
| No | 18 | 16.7 | 0.118 | 0.092 | ||||
| Yes | 44 | 62.9 | 1 | 0.06–0.24 | ˂0.001 * | 1 | 0.04–0.23 | ˂0.001 * |
| Hospitalized | ||||||||
| No | 60 | 34.3 | 0.261 | |||||
| Yes | 2 | 66.7 | 1 | 0.02–2.94 | 0.277 | |||
| Isolated | ||||||||
| No | 5 | 18.5 | 0.375 | |||||
| Yes | 57 | 37.7 | 1 | 0.13–1.04 | 0.061 | |||
| Family member has been infected with COVID-19 | ||||||||
| No | 4 | 14.3 | 0.264 | 0.382 | ||||
| Yes | 58 | 38.7 | 1 | 0.09–0.80 | 0.019 * | 1 | 0.09–1.53 | 0.174 |
| Family member hospitalized | ||||||||
| No | 50 | 33.3 | 0.667 | |||||
| Yes | 12 | 42.9 | 1 | 0.29–1.52 | 0.334 | |||
| DASS21 Depression | ||||||||
| Normal/Mild | 48 | 30.8 | 0.254 | 0.618 | ||||
| Mod.-Severe | 14 | 63.6 | 1 | 0.10–0.65 | 0.004 * | 1 | 0.11–3.38 | 0.579 |
| DASS21 Anxiety | ||||||||
| Normal/Mild | 38 | 28.8 | 0.371 | 0.723 | ||||
| Mod.-Severe | 24 | 52.2 | 1 | 0.19–0.74 | 0.005 * | 1 | 0.23–2.23 | 0.572 |
| DASS21 Stress | ||||||||
| Normal/Mild | 42 | 28.4 | 0.198 | 0.136 | ||||
| Mod.-Severe | 20 | 66.7 | 1 | 0.09–0.46 | ˂0.001 * | 1 | 0.03–0.53 | 0.004 * |
| FCV-19S | ||||||||
| Low | 18 | 18.7 | 0.199 | 0.242 | ||||
| High | 44 | 53.7 | 1 | 0.10–0.39 | ˂0.001 * | 1 | 0.11–0.55 | 0.001 * |
* Significant at p < 0.05.